PRANDIN Side Effects

6880352-3 | Blood Glucose Decreased, Dyspnoea, Swollen Tongue
on Jul 20, 2010 Female patient from UNITED STATES , weighting 230.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, dyspnoea, swollen tongue. Prandin dosage: Unk. During the same period patient was treated with BYETTA (Unk) (View Byetta Review and Byetta Label ), METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), FISH OIL (Unk) (View Fish Oil Review and Fish Oil Label ).

6748899-8 | Hepatotoxicity
Patient was taking Prandin (View Usage). Patient had the following side effects: hepatotoxicity on May 21, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, weighting 165.0 lb, was diagnosed with type 2 diabetes mellitus and. Prandin dosage: 0.5 Mg, Tid Before Meals Via Peg Tube. Patient was hospitalized.

6684427-3 | Hepatotoxicity
Adverse event was reported on Apr 06, 2010 by a Female patient taking Prandin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 78 years of age, After Prandin was administered, patient had the following side effects: hepatotoxicity. Patient was hospitalized.

6636529-5 | Blood Glucose Increased, Pancreatitis, Weight Decreased
on Mar 24, 2009 Male patient from UNITED STATES , 50 years of age, weighting 272.9 lb, was treated with Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, pancreatitis, weight decreased. Prandin dosage: Oral. During the same period patient was treated with BYETTA (10 Mcg) (View Byetta Review and Byetta Label ), PRECOSE (View Precose Review and Precose Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CINNAMON (CINNAMOMUM VERUM) (View Cinnamon (cinnamomum Verum) Review and Cinnamon (cinnamomum Verum) Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ).


6439449-4 | Blood Glucose Fluctuation, Body Temperature Increased, Flushing, Herpes Zoster
on Nov 03, 2009 Female patient from UNITED STATES , 85 years of age, weighting 110.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Prandin (View Usage). Patient had the following side effects: blood glucose fluctuation, body temperature increased, flushing, herpes zoster. Prandin dosage: 0.5 Mg, Bid. During the same period patient was treated with LASIX (Unk) (View Lasix Review and Lasix Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METOPROLOL (Unk) (View Metoprolol Review and Metoprolol Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), ACIDOPHILUS (Unk) (View Acidophilus Review and Acidophilus Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6390121-9 | Cerebrovascular Accident, Coronary Artery Disease, Heart Transplant Rejection
Patient was taking Prandin (View Usage). After Prandin was administered, patient had the following side effects: cerebrovascular accident, coronary artery disease (What is coronary artery disease?), heart transplant rejection on Sep 25, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with diabetes mellitus and. Prandin dosage: . Patient was hospitalized.

6075959-X | Dizziness, Fall, Liver Function Test Abnormal, Nausea, Oedema Peripheral, Pulmonary Hypertension, Renal Impairment
Adverse event was reported on Feb 03, 2009 by a Male patient taking Prandin (View Usage) (Dosage: Unk) was diagnosed with nocturia and. Location: UNITED STATES , 98 years of age, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), fall (What is fall?), liver function test abnormal, nausea (What is nausea?), oedema peripheral, pulmonary hypertension (What is pulmonary hypertension?), renal impairment. During the same period patient was treated with NORVASC (Unk) (View Norvasc Review and Norvasc Label ), UROXATRAL (View Uroxatral Review and Uroxatral Label ), NITROGLYCERIN (Unk) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6024710-8 | Breast Discomfort, Platelet Count Decreased
on Dec 22, 2008 Female patient from UNITED STATES , 72 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, depression (What is depression?), anxiety (What is anxiety?), colon cancer and was treated with Prandin (View Usage). Patient had the following side effects: breast discomfort, platelet count decreased. Prandin dosage: .5 Mg, Tid. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), MONOPRIL HCT (View Monopril-hct Review and Monopril-hct Label ), PAXIL CR (25 Mg, Qd) (View Paxil Cr Review and Paxil Cr Label ), XANAX (.25 Mg, Unk) (View Xanax Review and Xanax Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), OXIPLAT (View Oxiplat Review and Oxiplat Label ).

6017901-3 | Hepatitis Cholestatic
on Dec 15, 2008 Female patient from SPAIN , 77 years of age, weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Prandin (View Usage). After Prandin was administered, patient had the following side effects: hepatitis cholestatic. Prandin dosage: 6 Mg, Qd. During the same period patient was treated with METFORMIN HCL (1.7 G, Qd) (View Metformin Hcl Review and Metformin Hcl Label ).

5874880-7 | Hepatitis Cholestatic
Patient was taking Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic on Jun 20, 2007 from SPAIN Additional patient health information: Female patient , 77 years of age, weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and. Prandin dosage: 6 Mg, Qd. During the same period patient was treated with METFORMIN HCL (1.7 G, Qd) (View Metformin Hcl Review and Metformin Hcl Label ).

5857460-9 | Hypermetropia, Hypoglycaemia
Adverse event was reported on Aug 18, 2008 by a Female patient taking Prandin (View Usage) (Dosage: 1 Mg, Qd) . Location: UNITED KINGDOM , 76 years of age, Patient had the following side effects: hypermetropia, hypoglycaemia. During the same period patient was treated with TRIMETHOPRIM (200 Mg, Qd) (View Trimethoprim Review and Trimethoprim Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), DOXAZOSIN MESYLATE (4 Mg, Qd) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ENALAPRIL MALEATE (20 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), METFORMIN HCL (1 G, Qd) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5701619-8 | Chest Pain, Dyspepsia, Dyspnoea, Fatigue, Palpitations
on Apr 10, 2008 Male patient from UNITED STATES , weighting 187.6 lb, was treated with Prandin (View Usage). After Prandin was administered, patient had the following side effects: chest pain (What is chest pain?), dyspepsia, dyspnoea, fatigue, palpitations. Prandin dosage: 0.1mg Once Tab Tid (qwk) Po.

5664086-9 | Constipation, Transient Ischaemic Attack
on Mar 04, 2008 Female patient from UNITED STATES , 61 years of age, was diagnosed with type 2 diabetes mellitus, constipation (What is constipation?) and was treated with Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), transient ischaemic attack. Prandin dosage: 1 Tab, Tid. During the same period patient was treated with MIRALAX (Unk, Prn) (View Miralax Review and Miralax Label ), LASIX (View Lasix Review and Lasix Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), FIORICET (View Fioricet Review and Fioricet Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), DIOVAN /01319601/ (View Diovan /01319601/ Review and Diovan /01319601/ Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

5588083-7 | Lymphangiectasia Intestinal, Protein-losing Gastroenteropathy, Sepsis
Patient was taking Prandin (View Usage). Patient had the following side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis (What is sepsis?) on Jan 02, 2008 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and. Prandin dosage: .5 Mg, Tid. During the same period patient was treated with TRIAMTERENE (100 Mg, Qd) (View Triamterene Review and Triamterene Label ), OMEPRAZOLE (40 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), DIGOXIN (.1 Mg, Qd) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5395114-6 | Hepatitis Cholestatic
Adverse event was reported on Jun 20, 2007 by a Female patient taking Prandin (View Usage) (Dosage: 6 Mg, Qd) was diagnosed with type 2 diabetes mellitus and. Location: SPAIN , 77 years of age, weighting 154.3 lb, After Prandin was administered, patient had the following side effects: hepatitis cholestatic. During the same period patient was treated with METFORMINE (1.7 G, Qd) (View Metformine Review and Metformine Label ).

5379937-5 | Lymphangiectasia Intestinal, Protein-losing Gastroenteropathy, Sepsis
on Jun 25, 2007 Male patient from UNITED STATES , 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis (What is sepsis?). Prandin dosage: .5 Mg, Tid. During the same period patient was treated with TRIAMTERENE (100 Mg, Qd) (View Triamterene Review and Triamterene Label ), OMEPRAZOLE (40 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), DIGOXIN (.1 Mg, Qd) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5357629-6 | Granulocytopenia
on May 31, 2007 Female patient from SPAIN , 83 years of age, was treated with Prandin (View Usage). Patient had the following side effects: granulocytopenia. Prandin dosage: 1 Mg, Qd. During the same period patient was treated with RENITECMAX (View Renitecmax Review and Renitecmax Label ), TAZOCEL (.5 G, Bid) (View Tazocel Review and Tazocel Label ), CITALOPRAM /00582602/ (20 Mg, Qd) (View Citalopram /00582602/ Review and Citalopram /00582602/ Label ), OMEPRAZOL /00661201/ (20 Mg, Qd) (View Omeprazol /00661201/ Review and Omeprazol /00661201/ Label ), SEGURIL /00032601/ (Unk, Unk) (View Seguril /00032601/ Review and Seguril /00032601/ Label ), PLANTABEN /00029102/ (3.5 Mg, Bid) (View Plantaben /00029102/ Review and Plantaben /00029102/ Label ), SINTROM (4 Mg, Bid) (View Sintrom Review and Sintrom Label ), LOITIN (25 Mg, Qd) (View Loitin Review and Loitin Label ).

5334479-8 | Myelodysplastic Syndrome
Patient was taking Prandin (View Usage). After Prandin was administered, patient had the following side effects: myelodysplastic syndrome on May 15, 2007 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, ill-defined disorder and. Prandin dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), FLOMAX /01280302/ (View Flomax /01280302/ Review and Flomax /01280302/ Label ), COZAAR (View Cozaar Review and Cozaar Label ), TOFRANIL /00053902/ (View Tofranil /00053902/ Review and Tofranil /00053902/ Label ).

5322538-5 | Blood Glucose Increased
Adverse event was reported on Jan 22, 2007 by a Female patient taking Prandin (View Usage) (Dosage: See Image) was diagnosed with diabetes mellitus non-insulin-dependent and. Location: UNITED STATES , 75 years of age, weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased. During the same period patient was treated with TARKA (View Tarka Review and Tarka Label ), COZAAR (View Cozaar Review and Cozaar Label ), ZOCOR (View Zocor Review and Zocor Label ), NOVOLOG MIX 70/30 (INSULIN ASPART) SUSPENSION FOR INJECTION (View Novolog Mix 70/30 (insulin Aspart) Suspension For Injection Review and Novolog Mix 70/30 (insulin Aspart) Suspension For Injection Label ).

5322526-9 | Anaphylactic Shock
on Aug 07, 2006 Male patient from UNITED STATES , 41 years of age, weighting 259.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Prandin (View Usage). Patient had the following side effects: anaphylactic shock. Prandin dosage: 1 Mg, Tid, Oral. Patient was hospitalized.

5322096-5 | Anaphylactic Shock
on Aug 07, 2006 Male patient from UNITED STATES , 41 years of age, weighting 259.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Prandin (View Usage). After Prandin was administered, patient had the following side effects: anaphylactic shock. Prandin dosage: 1 Mg, Tid, Oral. Patient was hospitalized.

5290681-5 | Hyperglycaemia, Polydipsia, Polyuria, Renal Failure, Treatment Noncompliance, Vision Blurred
Patient was taking Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia, polydipsia, polyuria, renal failure, treatment noncompliance, vision blurred on Apr 05, 2007 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and. Prandin dosage: 2 Mg Po Tid. During the same period patient was treated with GLIPIZIDE (10 Mg Po Qd) (View Glipizide Review and Glipizide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NADOLOL (View Nadolol Review and Nadolol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), ZINC SULFATE (View Zinc Sulfate Review and Zinc Sulfate Label ). Patient was hospitalized.

5170830-X | Blood Glucose Decreased, Dizziness, Hyperhidrosis
Adverse event was reported on Dec 06, 2006 by a Male patient taking Prandin (View Usage) (Dosage: Tablet) . Location: UNITED STATES , 65 years of age, Patient had the following side effects: blood glucose decreased, dizziness (What is dizziness?), hyperhidrosis.

5060145-2 | Transient Ischaemic Attack
on Mar 06, 2006 Male patient from UNITED STATES , 71 years of age, weighting 229.3 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension, blood cholesterol increased and was treated with Prandin (View Usage). After Prandin was administered, patient had the following side effects: transient ischaemic attack. Prandin dosage: 1 Mg, Tid. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), DIOVAN (View Diovan Review and Diovan Label ), LIPITOR /NET/ (View Lipitor /net/ Review and Lipitor /net/ Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

5016492-3 | Angioneurotic Oedema
on May 23, 2006 Male patient from UNITED STATES , 68 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension, blood cholesterol increased and was treated with Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: angioneurotic oedema. Prandin dosage: 1 Mg, Tid. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GLUCOPHAGE /00082701/ (View Glucophage /00082701/ Review and Glucophage /00082701/ Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized.

4949499-2 | Intraocular Pressure Increased
Patient was taking Prandin (View Usage). Patient had the following side effects: intraocular pressure increased on Jan 31, 2006 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus non-insulin-dependent, glaucoma (What is glaucoma?) and. Prandin dosage: 1.0-1.5 Mg, Tid. During the same period patient was treated with ALPHAGAN (Unk, Bid) (View Alphagan Review and Alphagan Label ), XALATAN (Unk, Qd) (View Xalatan Review and Xalatan Label ).

4947955-4 | Convulsion
Adverse event was reported on Mar 06, 2006 by a Male patient taking Prandin (View Usage) (Dosage: 1 Mg, Tid) was diagnosed with diabetes mellitus non-insulin-dependent, hypertension, blood cholesterol increased and. Location: UNITED STATES , 71 years of age, weighting 229.3 lb, After Prandin was administered, patient had the following side effects: convulsion. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), DIOVAN (View Diovan Review and Diovan Label ), LIPITOR /NET/ (View Lipitor /net/ Review and Lipitor /net/ Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

4918437-0 | Urticaria
on Feb 17, 2006 Male patient from UNITED STATES , 62 years of age, weighting 330.0 lb, was treated with Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria. Prandin dosage: .

4916859-5 | Bacteraemia, Escherichia Urinary Tract Infection, Hepatitis, Sepsis
on Jan 23, 2006 Female patient from SPAIN , 78 years of age, was diagnosed with diabetes mellitus, cardiac failure and was treated with Prandin (View Usage). Patient had the following side effects: bacteraemia, escherichia urinary tract infection, hepatitis (What is hepatitis?), sepsis (What is sepsis?). Prandin dosage: 8 Mg, Qd. During the same period patient was treated with METFORMINE ^MERCK^ (1700 Mg, Qd) (View Metformine ^merck^ Review and Metformine ^merck^ Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), TORSEMIDE (10 Mg, Qd) (View Torsemide Review and Torsemide Label ), ADIRO (View Adiro Review and Adiro Label ), TEPAZEPAN (View Tepazepan Review and Tepazepan Label ), INSULIN (36 Iu, Unk) (View Insulin Review and Insulin Label ). Patient was hospitalized.

4901122-9 | Intraocular Pressure Increased
Patient was taking Prandin (View Usage). After Prandin was administered, patient had the following side effects: intraocular pressure increased on Jan 31, 2006 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus non-insulin-dependent, glaucoma (What is glaucoma?) and. Prandin dosage: 1.0-1.5 Mg, Tid. During the same period patient was treated with ALPHAGAN (Unk, Bid) (View Alphagan Review and Alphagan Label ), XALATAN (Unk, Qd) (View Xalatan Review and Xalatan Label ).

4899395-4 | Hepatitis
Adverse event was reported on Jan 23, 2006 by a Male patient taking Prandin (View Usage) (Dosage: 8 Mg, Qd) . Location: SPAIN , 78 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). During the same period patient was treated with METFORMINE ^MERCK^ (1700 Mg, Qd) (View Metformine ^merck^ Review and Metformine ^merck^ Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), TORSEMIDE (10 Mg, Qd) (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

4897748-1 | Convulsion, Speech Disorder
on Jan 30, 2006 Male patient from UNITED STATES , 71 years of age, weighting 235.0 lb, was diagnosed with diabetes mellitus and was treated with Prandin (View Usage). Patient had the following side effects: convulsion, speech disorder. Prandin dosage: 2 Pills 2 X Per Day Po.

4864596-8 | Cellulitis, Pneumonia
on Dec 15, 2005 Female patient from UNITED STATES , 83 years of age, weighting 105.8 lb, was diagnosed with diabetes mellitus non-insulin-dependent, cardiac failure congestive, cardiac disorder, anaemia, prophylaxis, osteoporosis (What is osteoporosis?) and was treated with Prandin (View Usage). After Prandin was administered, patient had the following side effects: cellulitis (What is cellulitis?), pneumonia (What is pneumonia?). Prandin dosage: 2 Tab, Tid. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NOVODILTAZEM (View Novodiltazem Review and Novodiltazem Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), POTASSIUM (View Potassium Review and Potassium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), OSCAL 500 D (View Oscal 500-d Review and Oscal 500-d Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

4839435-1 | Cerebrovascular Accident, Chest Pain, Coronary Artery Disease, Depression, Glaucoma, Heart Rate Irregular, Hyperkalaemia, Iritis, Microalbuminuria
Patient was taking Prandin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, chest pain (What is chest pain?), coronary artery disease (What is coronary artery disease?), depression (What is depression?), glaucoma (What is glaucoma?), heart rate irregular, hyperkalaemia, iritis, microalbuminuria on Aug 10, 2005 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 213.8 lb, . Prandin dosage: . During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), NITROQUICK (View Nitroquick Review and Nitroquick Label ), ULTRAM (View Ultram Review and Ultram Label ). Patient was hospitalized and became disabled.

4609111-9 | Idiopathic Thrombocytopenic Purpura
Adverse event was reported on Dec 02, 2004 by a Female patient taking Prandin (View Usage) (Dosage: 0. 5mg Tid Per Oral) was diagnosed with diabetes mellitus and. Location: , 91 years of age, weighting 155.9 lb, Patient had the following side effects: idiopathic thrombocytopenic purpura. Patient was hospitalized.

4565548-8 | Ultrasound Liver Abnormal, Weight Decreased, White Blood Cell Count Increased
on Jan 19, 2005 Female patient from , 69 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Prandin (View Usage). After Prandin was administered, patient had the following side effects: ultrasound liver abnormal, weight decreased, white blood cell count increased. Prandin dosage: Unk, Tid.